As of May 22
| +0.03 / +2.21%|
The 2 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 5.08, with a high estimate of 6.17 and a low estimate of 3.99. The median estimate represents a +265.52% increase from the last price of 1.39.
The current consensus among 2 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.